BICO Group ABCLLKF -7.36%63 PB Ratio is 0.72 as of Jun. 26, 2026, which is 80% below its 10-year median of 3.63. GuruFocus rates CLLKF with a GF Score™ of 63/100 and a GF Value™ of $3.69 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, BICO Group AB ranks better than 87.69% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), BICO Group AB's share price is $1.762. BICO Group AB's Book Value per Share for the quarter that ended in Mar. 2026 was $2.45. Hence, BICO Group AB's PB Ratio of today is 0.72.
The historical rank and industry rank for BICO Group AB's PB Ratio or its related term are showing as below:
CLLKF'
s PB Ratio Range Over the Past 10 Years
Min: 0.25 Med: 3.63 Max: 26.08
Current: 0.73
During the past 10 years, BICO Group AB's highest PB Ratio was 26.08. The lowest was 0.25. And the median was 3.63.
CLLKF's PB Ratio is ranked better than 87.69% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs CLLKF: 0.73
During the past 12 months, BICO Group AB's average Book Value Per Share Growth Rate was -39.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -36.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -13.20% per year.
During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of BICO Group AB was 381.90% per year. The lowest was -36.80% per year. And the median was 90.80% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
BICO Group AB PB Ratio Related Terms
BICO Group AB PB Ratio Historical Data
* Premium members only.
The historical data trend for BICO Group AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, BICO Group AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BICO Group AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where BICO Group AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
BICO Group AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
BICO Group AB (CLLKF) has a PB Ratio of 0.72 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BICO Group AB and its competitors. This is 80% below median its historical median of 3.63. Over the past decade, BICO Group AB's PB Ratio has ranged from 0.25 to 26.08. According to the industry distribution chart, BICO Group AB ranks #97 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 12.3%.
Is BICO Group AB's PB Ratio too high?
BICO Group AB's current PB Ratio of 0.72 is 80% below median its 10-year median of 3.63. Over the past 10 years, this metric has ranged from a low of 0.25 to a high of 26.08. The Medical Devices & Instruments industry median PB Ratio is 2.02. BICO Group AB's value of 0.72 is 64.4% below this industry median. Based on the distribution chart, BICO Group AB ranks #97 out of 788 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, BICO Group AB has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BICO Group AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, BICO Group AB ranks #97 out of 788 companies for PB Ratio. This places BICO Group AB in the top 12% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.02. BICO Group AB's value of 0.72 is 64.4% below this benchmark. Historically, BICO Group AB's own PB Ratio has ranged from 0.25 to 26.08 over the past decade. While the company's 10-year median is 3.63 vs. the industry median of 2.02, BICO Group AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BICO Group AB's current PB Ratio of 0.72 is 64.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on BICO Group AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BICO Group AB's current PB Ratio is 0.72, which is 80% below median its own 10-year median of 3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BICO Group AB stock overvalued right now?
Based on GuruFocus' analysis, BICO Group AB (CLLKF) is currently considered Possible Value Trap. The stock's GF Value™ is $3.69, compared to a current price of $1.76 — trading 52.2% below its estimated fair value. The current PB Ratio is 0.72, which is 80% below median its 10-year median of 3.63 and 64.4% below the Medical Devices & Instruments industry median of 2.02. BICO Group AB's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For BICO Group AB (CLLKF), the current PB Ratio is 0.72 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BICO Group AB (CLLKF) Overvalued in 2026?
Based on GuruFocus' analysis, BICO Group AB stock appears to be undervalued.
The current stock price of $1.76 is trading 52.2% below its estimated GF Value™ of $3.69.
GuruFocus considers BICO Group AB to be Possible Value Trap.
Key valuation signals for CLLKF:
PB Ratio: 0.72 (80% below median its 10-year median of 3.63)
GF Value™: $3.69 vs. price of $1.76 (52.2% below fair value)
Industry Position: 64.4% below the Medical Devices & Instruments median (#97 of 788)
No single metric tells the full story. See the CLLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BICO Group AB provides hardware, laboratory automation software, and products to automate and increase efficiency in workflows for pharma and biotech companies. Its portfolio includes automated workstations, lab automation software, microscopes and live-cell imaging, 3D cell culture and bioprinting, single-cell dispensing, liquid handling, mixing technologies, and consumables. The Group operates through two segments: Life Science Solutions, the maximum revenue generator, including CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, Cellenion, CELLINK, and BioMatrix, and Lab Automation, consisting of Biosero, which provides the Green Button Go Suite software and automation integration services.
63GF Score
Get the complete analysis for CLLKF
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLLKF has been successfully added to your 
